Evidence map›Paper›PMID 21717079›Full record

ReviewImmunologic research2011

Regulation of NF-κB induction by TCR/CD28.

Jing Cheng, Angela Montecalvo, Lawrence P Kane

Open access · greenAbstract readReview
In one paragraph

Review in Immunologic research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. NF-κB in inflammation and cancer.Cellular & molecular immunology · 2025
    Review
  7. Article
  8. Frontiers in veterinary science · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ameliorative Effect of Citropten Isolated fromMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. CD137 (4-1BB) costimulation of CD8Nature communications · 2021
    Article
  16. Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jing ChengDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Angela Montecalvo
Lawrence P Kane
University of Pittsburgh · US

Funding

Regulation of NF-kB by the Akt kinaseR01GM080398 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KANE, LAWRENCE P. · 2007 to 2010
$1.3M
NIGMS NIH HHS R01 GM080398
6 · The paper itself

Abstract

NF-κB family transcription factors are a common downstream target for inducible transcription mediated by many different cell-surface receptors, especially those receptors involved in inflammation and adaptive immunity. It is now clear that different classes of receptors employ different proximal signaling strategies to activate the common NF-κB signaling components, such as the IKK complex. For antigen receptors expressed by T and B cells, this pathway requires a complex of proteins including the proteins Carma1, Bcl10, and Malt1. Here, we discuss some of what is known about regulation of these proteins downstream of TCR/CD3 and co-stimulatory CD28 signaling. We also discuss another unique aspect of TCR-mediated NF-κB activation, i.e., the spatial restriction imposed on signaling events by the formation of the immunological synapse between a T cell and antigen-presenting cell presenting specific peptide/MHC.

Indexed as

AnimalsCD28 AntigensHumansLymphocyte ActivationNF-kappa BReceptors, Antigen, T-CellSignal TransductionT-LymphocytesCD28 AntigensNF-kappa BReceptors, Antigen, T-Cell

Identifiers

PMID21717079
PMCPMC4066383
OpenAlexW2012050707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.